Humana Inc. HUM
Set alert
At close
Pre-market · Nov 2, 7:28 AM ET
- YTD
- +61.83%
- 1 year
- +49.00%
- Open
- 415.66
- Prev close
- 416.68
- Mkt cap
- 49.77B
- Vol
- 839.19K
- Avg vol
- 1.25M
- EPS
- 10.58
- P/E
- 39.18
- Div yield
- 0.85%
More statistics
- Low
- 409.44
- High
- 420.28
- Forward P/E
- 24.26
- Beta
- 0.74
- Short ratio
- 2.41
- Inst. own
- 102.04%
- Dividend
- 3.54
- Ex-div date
- Oct 29, 2026
- Earnings
- Nov 6, 2026
- 50-d avg
- 400.35
- 200-d avg
- 307.64
- 1y target
- 465.13
6M chart
Events in this range
- Jun 26, 2026Dividend: 0.885
- Jul 29, 2026Earnings: 7.61; estimate 7.27; surprise 4.68%
- Oct 9, 2026Rating: Barclays · Overweight → Overweight
- Oct 12, 2026Rating: Raymond James · Market Perform → Outperform
- Oct 12, 2026Rating: Oppenheimer · Outperform → Outperform
- Oct 12, 2026Rating: Truist Securities · Hold → Hold
- Oct 12, 2026Rating: UBS · Neutral → Neutral
- Oct 13, 2026Rating: Mizuho · Outperform → Outperform
- Oct 30, 2026Dividend: 0.885
Signals (28)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 26, 2026 | 6 days ago |
| MACD: Buy Signal | Oct 5, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 2, 2026 | 1 month ago |
| SMA: Bearish | Sep 30, 2026 | 1 month ago |
| SMA: Bullish | Sep 25, 2026 | 1 month ago |
| SMA: Bearish | Sep 16, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 16, 2026 | 1 month ago |
| SMA: Bullish | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 24, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 20, 2026 | 2 months ago |
| SMA: Bearish | Aug 18, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 13, 2026 | 2 months ago |
| SMA: Bullish | Aug 12, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
| SMA: Bullish | Aug 7, 2026 | 2 months ago |
| SMA: Bearish | Aug 4, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| SMA: Bearish | Jul 31, 2026 | 3 months ago |
| RSI: Overbought | Jul 13, 2026 | 3 months ago |
| RSI: Overbought | Jul 8, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 6, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 1, 2026 | 4 months ago |
| RSI: Overbought | Jun 25, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 17, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 4, 2026 | 5 months ago |
| MACD: Sell Signal | May 27, 2026 | 5 months ago |
Key statistics
- Market cap
- 49.78B
- Enterprise value
- 41.08B
- Trailing P/E
- 39.18
- Forward P/E
- 24.26
- PEG ratio
- 1.15
- Price / sales
- 0.34
- Price / book
- 2.59
- EPS (TTM)
- 10.58
- Beta
- 0.74
- Dividend yield
- 0.85%
- Payout ratio
- 33.46%
- Profit margin
- 0.88%
- Revenue (TTM)
- 145.68B
- Revenue growth
- 26.20%
- Free cash flow
- 1.94B
- Total cash
- 23.87B
- Total debt
- 14.74B
- Return on equity
- 6.89%
- Shares outstanding
- 120.08M
- Short % of float
- 3.47%
- 50-day average
- 400.35
- 200-day average
- 307.64
Analyst view
Consensus: buy
- Target (low)
- 280.00
- Target (mean)
- 465.13
- Target (high)
- 596.00
- Strong buy3
- Buy13
- Hold9
- Sell1
- Strong sell0
Next earnings
Nov 6, 2026
Expected Nov 6, 2026. Consensus EPS estimate -1.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 6, 2026 | Sep 30, 2026 | -1.00 | — | — | — |
| Jul 29, 2026 | Jun 30, 2026 | 7.27 | 7.61 | +0.34 | +4.68% |
| Apr 29, 2026 | Mar 31, 2026 | 10.24 | 10.31 | +0.07 | +0.68% |
| Feb 11, 2026 | Dec 31, 2025 | -4.00 | -3.96 | +0.04 | +1.00% |
| Nov 5, 2025 | Sep 30, 2025 | 2.93 | 3.24 | +0.31 | +10.58% |
| Jul 30, 2025 | Jun 30, 2025 | 5.92 | 6.27 | +0.35 | +5.91% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 13, 2026 | Mizuho | main | Outperform | Outperform |
| Oct 12, 2026 | UBS | main | Neutral | Neutral |
| Oct 12, 2026 | Truist Securities | main | Hold | Hold |
| Oct 12, 2026 | Oppenheimer | main | Outperform | Outperform |
| Oct 12, 2026 | Raymond James | up | Market Perform | Outperform |
| Oct 9, 2026 | Barclays | main | Overweight | Overweight |
About Humana Inc.
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Country
- United States
- Website
- humana.com
News
- Analysts Estimate Humana (HUM) to Report a Decline in Earnings: What to Look Out for
- Humana Board Declares Payment of Quarterly Dividend to Stockholders
- Baron Health Care Fund: Q3 2026 New Positions And Exits
- QUICK SPARK: UnitedHealth Calls 2026 the Bottom for Medicaid Margins
- Humana To Rally Over 14%? Here Are 10 Top Analyst Forecasts For Tuesday
- Mizuho Maintains Outperform on Humana, Raises Price Target to $495
- Humana Forms JV With BlackRock To Manage And Operate Existing Network Of CenterWell Senior Primary Care Clinics; Reaffirms FY26 Adjusted EPS Guidance
- Truist Securities Maintains Hold on Humana, Raises Price Target to $475
- Oppenheimer Maintains Outperform on Humana, Raises Price Target to $525
- DataMeds AI Stock Rises After Humana Adds Medicaid Coverage for ChemoFx Cancer Test
Your note
Sign in to keep a note on HUM — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Dodge & Cox Inc. | 9.11% | 10,940,380 | 4.54B | Jun 29, 2026 |
| Blackrock Inc. | 8.68% | 10,417,803 | 4.32B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 6.53% | 7,843,620 | 3.25B | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.85% | 5,818,956 | 2.41B | Jun 29, 2026 |
| State Street Corporation | 4.54% | 5,457,072 | 2.26B | Jun 29, 2026 |
| Pzena Investment Management LLC | 3.67% | 4,403,136 | 1.83B | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Dodge & Cox Funds-Dodge & Cox Stock Fund | 6.12% | 7,354,500 | 3.05B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 3,811,711 | 1.58B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.59% | 3,111,659 | 1.29B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund | 2.17% | 2,601,473 | 1.08B | Jun 29, 2026 |
| AMERICAN FUNDS FUNDAMENTAL INVESTORS | 1.41% | 1,690,812 | 700.91M | Sep 29, 2026 |
| iShares Trust-iShares Core S&P 500 ETF | 1.33% | 1,600,377 | 663.42M | Sep 29, 2026 |